IgA肾病系膜增殖性足细胞病:损伤与进展机制新见解
本文综述IgA肾病中足细胞病的机制。IgA肾病虽以系膜区免疫复合物沉积为原发部位,但持续蛋白尿和进展主要与足细胞损伤相关;系膜区信号驱动足细胞足突改变、脱落,促进局灶节段性硬化和肾功能丢失,新药靶点应兼顾系膜细胞与足细胞功能。
要点
- IgA肾病进展主要与足细胞损伤所致持续蛋白尿相关
- 系膜区IgA免疫物沉积后信号可导致足细胞足突改变与脱落
- 足细胞病促进局灶节段性硬化及肾功能进行性丢失
核心结论
- IgA肾病虽为系膜性疾病,但足细胞损伤是持续蛋白尿和进展的重要环节。
- 足细胞病不仅促进局灶节段性硬化,也促进肾功能进行性丢失。
- 新药靶点不应仅降低系膜细胞活性和炎症反应,还应改善足细胞功能与存活。
研究设计与样本
- 综述类文章,汇总近期关于IgA肾病足细胞病机制的数据。
主要发现
- IgA肾病初始病变为系膜区IgA免疫物沉积、系膜细胞增殖和基质过多沉积。
- 足细胞病变继发于系膜区改变,受系膜来源信号影响,持续损伤后足细胞从肾小球基底膜脱落。
- 足细胞病促进局灶节段性硬化并促进肾功能进行性丢失。
- 皮质激素/免疫抑制治疗能否预防或治愈这些足细胞病变仍有争议。
临床怎么用
- 临床评估IgA肾病进展时除系膜病变外,应关注足细胞损伤及持续蛋白尿。
- 开发或选择治疗时,可考虑兼顾改善足细胞功能与存活的策略。
局限性
- 皮质激素/免疫抑制能否预防或治愈足细胞病变仍有争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunoglobulin A nephropathy (IgAN) was defined as a mesangiopathic disease, since the primary site of deposition of IgA immune material is the mesangium, and proliferation of mesangial cells and matrix excess deposition are the first histopathologic lesions. However, the relentless silent progression of IgAN is mostly due to the development of persistent proteinuria, and recent studies indicate that a major role is played by previous damage of function and anatomy of podocytes. In IgAN, the podocytopathic changes are the consequence of initial alterations in the mesangial area with accumulation of IgA containing immune material. Podocytes are therefore affected by interactions of messages originally driven from the mesangium. After continuous insult, podocytes detach from the glomerular basement membrane. This podocytopathy favours not only the development of glomerular focal and segmental sclerosis, but also the progressive renal function loss. It is still debated whether these lesions can be prevented or cured by corticosteroid/immunosuppressive treatment. We aimed to review recent data on the mechanisms implicated in the podocytopathy present in IgAN, showing new molecular risk factors for progression of this disease. Moreover, these observations may indicate that the target for new drugs is not only focused on decreasing the activity of mesangial cells and inflammatory reactions in IgAN, but also on improving podocyte function and survival.
引用
- Trimarchi H, Coppo R. Podocytopathy in the mesangial proliferative immunoglobulin A nephropathy: new insights into the mechanisms of damage and progression. Nephrol Dial Transplant. 2019. PMID: 30698804. doi:10.1093/ndt/gfy413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。